BT

BCM Technologies (BCMT)

North America, Texas, United States, Houston

Description

BCM Technologies’ investment strategy revolves around the concept that maximum returns from early stage life science investing will result

Investor Profile

BCM Technologies (BCMT) has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Medical, Bioinformatics.

Stage Focus

  • Series B (67%)
  • Post Ipo Equity (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Bioinformatics
  • Pharmaceutical
  • Developer Platform
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BCM Technologies (BCMT) frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Bay City Capital
North America, California, United States, San Francisco
Co-Investments: 1
The Walden Group
North America, New York, United States, Tarrytown
Co-Investments: 1
CV
North America, Texas, United States, Houston
Co-Investments: 1
Boston Millennia Partners
North America, Massachusetts, United States, Boston
Co-Investments: 1
PZ
North America, New York, United States, New York
Co-Investments: 1
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Co-Investments: 1
GeneChem
North America, Quebec, Canada, Montréal
Co-Investments: 1
SS
North America, Quebec, Canada, Montréal
Co-Investments: 1

What are some of recent deals done by BCM Technologies (BCMT)?

Relievant Medsystems

Minneapolis, Minnesota, United States

Relievant Medsystems is a medical device company specializing in diagnosing and treating chronic low back pain.

BiotechnologyHealth CareMedical
Series BOct 22, 2006
Amount Raised: $5,050,000
Rejuvenon

The Woodlands, Texas, United States

Rejuvenon a biopharmaceutical company committed developing and commercializing promising compounds for treatment of oncologic diseases.

BiotechnologyDeveloper PlatformMedical
Series BJun 23, 2004
Amount Raised: $37,000,000
Lexicon Pharmaceuticals

The Woodlands, Texas, United States

Lexicon Pharmaceuticals is a biopharmaceutical company that discovers and develops precise medicines for human disease.

BioinformaticsBiotechnologyMedicalPharmaceutical
Post Ipo EquityJan 1, 1999
Amount Raised: $31,800,000